Historic settlement for over 1,300 survivors of clergy and adult abuse within the Roman Catholic Archdiocese of Los Angeles, marking a pivotal moment for justice.
April 15, 2015
Johnson & Johnson and Boston Scientific Corp. — two manufacturers of vaginal mesh implants that have caused injuries to many women across the nation — have lost their bid to toss almost 100 transvaginal mesh cases out of court in Pennsylvania.
The pelvic mesh cases are pending in the Philadelphia County Court of Common Pleas where a mass tort program has been set up to handle the multitude of claims being filed. J&J and Boston Scientific had argued that many of the lawsuits did not have sufficient links with Pennsylvania to be filed there. Judge Arnold New rejected the argument.
J&J attempted to persuade the Pennsylvania judge that the injured women had the burden of proving that the Pennsylvania court had jurisdiction over the lawsuits. But lawyers representing the pelvic mesh victims pointed out that the medical device makers had agreed to defend lawsuits in Pennsylvania when they officially registered to do business in the state with the Pennsylvania Secretary of State’s office. This isreportedly the result that a federal judge in Delaware reached when deciding the same issue.
There are more than 500 transvaginal mesh lawsuits pending in Pennsylvania’s mass tort program.
We understand that injuries caused by pelvic mesh are personal and they’re sensitive. That’s why we’ve assembled a legal team, most of whom are women, to provide our TVM clients with compassionate and aggressive representation throughout the entire course of litigation. To learn more about Waters Kraus Paul & Siegel, or to have one of our attorneys review your potential pelvic sling case, contact usby email or call our transvaginal mesh lawyers, like Kyla Cole in our Texas office, at800.226.9880.
Our Results
Historic settlement for over 1,300 survivors of clergy and adult abuse within the Roman Catholic Archdiocese of Los Angeles, marking a pivotal moment for justice.
A Philadelphia jury awarded a record verdict against ExxonMobil for failing to warn about cancer risks due to benzene in its petroleum products.
Private equity firm and co-defendants agree to pay $25M in Medicaid fraud case alleging mental health services provided by unqualified providers.